医学
黄斑变性
血管抑制剂
随机对照试验
眼科
生物仿制药
贝伐单抗
内科学
化疗
作者
Jan Hamouz,Agnieszka Nowosielska,Anna Święch-Zubilewicz,Santiago Abengoechea,Kristīne Baumane,Attila Vajas,Małgorzata Siewierska,Milan Veselovsky,Miroslav Veith,Ágnes Kerényi,Shobhana Mange,Krishnapada Baidya,Guna Laganovska,Ignasi Jürgens,András Papp,Jignesh Gosai,Jana Štefaničková,Mei Han,Piotr Fryczkowski,Dominik Zalewski,Jing Wang,Wenbin Wei
标识
DOI：10.1016/j.oret.2024.10.001
摘要
This study aimed to demonstrate the clinical equivalence of biosimilar QL1205 and reference ranibizumab, Lucentis®, in patients with neovascular age-related macular degeneration (nAMD).
科研通智能强力驱动
Strongly Powered by AbleSci AI
薰硝壤
不配.
Henry
浅尝离白
个性的紫菜
有人
iNk
Singularity
寻道图强
Leonardi
8R60d8
竹筏过海
pcr163
肯德鸭
咖啡豆
itsserene
乐乐乐乐乐乐
yufanhui
LY
tuanheqi
皖公网安备34019202002308
